Kengo Takeuchi - Concepedia

Author

Kengo Takeuchi

Japanese Foundation For Cancer Research ORCID

Also Known As

Chiho Obayashi, K TAKEUCHI, K Takeuchi, K. TAKEUCHI, K. Takeuchi, KENGO TAKEUCHI, Kengo TAKEUCHI, Kengo Takeuchi, Narittee Sukswai, Takeuchi Kengo

719

Publications

21.1K

Citations

H-Index

225

Concepts

All Affiliations

Japanese Foundation For Cancer Research The University of Tokyo The Cancer Institute Hospital Jichi Medical University Kyoto University

About

Kengo Takeuchi is an author at Japanese Foundation For Cancer Research specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	93	10.7K
2	Engineering	9	9	375
3	Health Sciences	9	9	384
4	Natural Sciences	6	6	192
5	Public Health	2	2	31

Kengo Takeuchi

210

Publications

19.6K

Citations

H-Index

Page 1

	Year	Citations
RET, ROS1 and ALK fusions in lung cancer Kengo Takeuchi, Manabu Soda, Yuki Togashi, Nature Medicine OncologyMedicineCancer GeneticsCancer BiologyCell Biology	2012	1.3K
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors Young Lim Choi, Manabu Soda, Yoshihiro Yamashita, New England Journal of Medicine PathologyFusion-type Tyrosine KinaseCancer BiologyAnaplastic Lymphoma KinaseTumor Biology	2010	1.2K
Integrated molecular analysis of adult T cell leukemia/lymphoma Keisuke Kataoka, Yasunobu Nagata, Akira Kitanaka, Nature Genetics Lymphoid NeoplasiaMedicineMixed-phenotype Acute LeukemiaMolecular AnalysisImmunology	2015	825
KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer Kengo Takeuchi, Young Lim Choi, Yuki Togashi, Clinical Cancer Research	2009	711
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers Keisuke Kataoka, Yuichi Shiraishi, Yohei Takeda, Nature Aberrant Pd-l1 ExpressionCancer Cell BiologyPathologyMolecular OncologyCancer Genetics	2016	627
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma Mamiko Sakata‐Yanagimoto, Terukazu Enami, Kenichi Yoshida, Nature Genetics Lymphoid NeoplasiaSomatic VariantImmunologyPathologyAdult T-cell Leukemia-lymphoma	2014	625
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study Takashi Seto, Katsuyuki Kiura, Makoto Nishio, The Lancet Oncology Non-small-cell Lung CancerMedicinePathologyAf-001jp StudyBronchial Neoplasm	2013	576
Frequent inactivation of A20 in B-cell lymphomas Motohiro Kato, Masashi Sanada, Itaru Kato, Nature Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology	2009	547
A mouse model for <i>EML4-ALK</i> -positive lung cancer Manabu Soda, Shuji Takada, Kengo Takeuchi, Proceedings of the National Academy of Sciences Fusion KinaseHuman Eml4-alk FormTumor MicroenvironmentMedicineCancer Cell Biology	2008	509
Multiplex Reverse Transcription-PCR Screening for <i>EML4-ALK</i> Fusion Transcripts Kengo Takeuchi, Young Lim Choi, Manabu Soda, Clinical Cancer Research	2008	502

Page 1